Biosimilars in paediatric inflammatory bowel disease

The introduction of biological treatments has changed disease outcomes for patients with inflammatory bowel disease. Biologicals have high efficacy, and can induce and maintain remission after failed responses to conventional immunosuppressive and/or steroid therapy. The increasing occurrence of sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieczkowska-Golub, Joanna, Jarzebicka, Dorota, Oracz, Grzegorz, Kierkus, Jaroslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148430/
https://www.ncbi.nlm.nih.gov/pubmed/30254406
http://dx.doi.org/10.3748/wjg.v24.i35.4021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148430/
https://www.ncbi.nlm.nih.gov/pubmed/30254406
http://dx.doi.org/10.3748/wjg.v24.i35.4021

Ejemplares similares